Xeris Biopharma Holdings (XERS) Tax Provisions (2022 - 2024)
Xeris Biopharma Holdings (XERS) posted Tax Provisions of -$3.3 million for Q3 2024, down 543.79% on a QoQ basis from $749000.0 in Q2 2024, and down 883.43% year-over-year from $424287.0 in Q4 2023.
Xeris Biopharma Holdings (XERS) Tax Provisions (2022 - 2024) Analysis & Trends
Xeris Biopharma Holdings' Tax Provisions history runs 3 years deep, the most recent figure standing at -$3.3 million for Q3 2024.
- Quarterly Tax Provisions fell 883.43% year-over-year to -$3.3 million in Q3 2024, while the trailing twelve-month figure through Jun 2025 was -$3.3 million (down 789.63% YoY) and the FY2024 annual result came in at -$2.3 million, down 81.59% from the prior year.
- Tax Provisions was -$3.3 million for Q3 2024 at Xeris Biopharma Holdings, down from $749000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $749000.0 in Q2 2024 and bottomed at -$3.3 million in Q3 2024.
- A 3-year average of -$494100.0 and a median of -$338500.0 in 2022 frame the typical range for Tax Provisions.
- Peak annual rise in Tax Provisions reached 210.96% in 2024, while the deepest fall reached 883.43% in 2024.
- Xeris Biopharma Holdings' Tax Provisions stood at -$338000.0 in 2022, then jumped by 30.18% to -$236000.0 in 2023, then slumped by 1308.47% to -$3.3 million in 2024.
- Business Quant data shows XERS's Tax Provisions at -$3.3 million in Q3 2024, $749000.0 in Q2 2024, and $307000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 67.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 157.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 676.90 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -423.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 48.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 30.00 Mn |
| 10 | Xeris Biopharma Holdings | 1.43 Bn | 1.32 Bn | 72.55 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -3.32 Mn |
| Jun 30, 2024 | 749,000.00 |
| Mar 31, 2024 | 307,000.00 |
| Dec 31, 2023 | -236,000.00 |
| Sep 30, 2023 | -338,000.00 |
| Jun 30, 2023 | -675,000.00 |
| Dec 31, 2022 | -338,000.00 |
| Sep 30, 2022 | -339,000.00 |
| Jun 30, 2022 | -339,000.00 |
| Mar 31, 2022 | -408,000.00 |